We would love to hear your thoughts about our site and services, please take our survey here.
When voting with H&L you need to notify them 5 days before. The BOD have got till 21st to get news out, no news no vote
The toxicology report for our 1801 is taking a bloody long time ??? Has it got lost in post
Good price for ii to buy in??
Repost
PROMISING EARLY SAFETY DATA
Toxicology results IMO is the deal maker?
I was just having a little browse through some resent RNSs and this kind of chilled me out!!!
Trading Statement 11th August 2020
OPERATIONAL HIGHLIGHTS
Selective TYK2/JAK1 Inhibitors in Autoimmune Diseases and Cancer
Sareum is continuing to advance its proprietary selective dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as potential once-daily, oral immunotherapy candidates, targeting autoimmune diseases (SDC-1801) and cancers (SDC-1802). Both molecules demonstrate high selectivity for TYK2 and JAK1 kinases, promising early safety data as well as compelling activity in relevant disease models. In addition, both programmes represent unique licensing opportunities for pharmaceutical partners as there are currently no marketed products with the selectivity profile of these molecules.
My favourite bit is ‘PROMISING EARLY SAFETY DATA’
Thinking we would know by now if something was up
2021 Trading update and notification of date of results posted 9th Feb -.Results 25th. I can see Feb 2022 being very interesting for CPX ? Hopefully news in this up and coming week
Toxicology results IMO is the deal maker?
I was just having a little browse through some resent RNSs and this kind of chilled me out!!!
Trading Statement 11th August 2020
OPERATIONAL HIGHLIGHTS
Selective TYK2/JAK1 Inhibitors in Autoimmune Diseases and Cancer
Sareum is continuing to advance its proprietary selective dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as potential once-daily, oral immunotherapy candidates, targeting autoimmune diseases (SDC-1801) and cancers (SDC-1802). Both molecules demonstrate high selectivity for TYK2 and JAK1 kinases, promising early safety data as well as compelling activity in relevant disease models. In addition, both programmes represent unique licensing opportunities for pharmaceutical partners as there are currently no marketed products with the selectivity profile of these molecules.
My favourite bit is ‘PROMISING EARLY SAFETY DATA’
Thinking we would know by now if something was up
Simply put Sareum have proved successful in research and development with the support of private investors over the years but now it’s time for commercialisation. Sareum need institutional investors ie pensions, banks, rich people to raise the MARKET CAP.. Reading what’s been said on board and the RNS a few times I’ve changed my tune I will be voting yes to Consolidation let’s move to the next level. Good night Fax, see you Billion £ MC time x
Just a question what would happen to SP if Positive Tox results were published? What would happen to SP if we entered agile covid project. What would happen to SP if licensing deal was announced? What would happen if partnering with other company for clinical trials. Answer IMO price goes up I sell at £Billion MC and institutions can have my shares consolidation alone won’t make me part with them??
Shame not positive Tox results now that would have been positive for investors and institutions. IMO only putting meat on bone will attract these financial entity’s. NO from me unless something substantial is Published In between I seem to remember another company that consolidated down to around 65 million….spooky.
The trouble with this share is you got those posters that would sap the life out of a unicorn and others that could raise the dead. Personally waiting for Tox and then Parker’s Covid pill news. Why tweet other wise
That happened to me also sold 2 million then week later brought back neither buy or sell showed up I invest/trade with H&L. This was month or so ago though spooky!!
Is there a trading up date soon for CPX
What is needed is Parker’s Covid pill and Thoth2 40 £billion MC now wouldn’t that be lovely. Now where are those Tox results
The tortoise wins in the end lol
Thanks for your update
……../.\
……/….\
…../…….\
…..|=====|
…..|…..…|
…..|..……|
…..|…..…|
.…/______\
…|_______|
…|……S…..|
…|……U…..|
…|.…...N…..|
…|……R…..|
…|….…I…..|
…|……S…..|
…|……E…..|
.../—|—|——| \
./__ |_|___|__\
/___|_|___|___\
….…/_\/_\
……######
…..##AGM##
……##PC##
……..£$¥£
……..#£$€
………$$
……….£
………##
………##
Let’s hope PC is not 3400 miles away
Still no RNS roll on tomorrow. My 40 grand could be doing with investing elsewhere hopefully he turns up at AGM
Is that 3 £billion per year to sareum via royalty payments with CHK1
So really stating that Mono estimated 3 billion a year in US alone. Would it not be prudent to fill one’s boots now at the low MC. What are we looking at if 737 goes the way that is possible 50 billion MC for Sierra????
Come On PC this is the only stock I hold that wasn’t invented by humans it is all ready in the ground. Granted you got to find it and then sell it but not to complicated. I would prefer CS was sold to CRMC then things could start moving faster here as in, find gold then mine it. The business model needs a kick up the arse lol